ArticleLeukemia2021

Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo.

Christoph Rummelt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.